New patent for Pharmacyclics Inc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…


Biotechblog